Ruti Aga Handed Six-Year Ban: Fake Prescription Issued by a Family Member Ends the Marathon Star's Career

Ethiopian marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU), the outcome of two separate violations stacked together: the presence of a prohibited substance, and the fabrication of a medical document used to explain it. The AIU announced the sanction in a statement on Thursday, with the ban backdated to 10 September — the date her provisional suspension took effect.

The story is not really about performance. The race in question carries no disclosed mark, no splits, no field data. Its real information value lies in three things: the arithmetic of the sanction, what the forged prescription reveals about medical governance inside East African road-racing entourages, and a technical misdescription of the substance that needs correcting.

How the six years add up

The structure of the AIU decision is straightforward. Two years for the presence violation, four years for tampering — six in total. Both figures are standard under the World Anti-Doping Code, not exceptional. A two-year sanction typically reflects a Specified Substance finding without proven intent; four years is the Code's standard tampering penalty.

The arithmetic carries a second message. Had Aga produced genuine medical records and demonstrated the route and timing of administration, she had a legitimate pathway to a no-fault or no-significant-fault finding, which could have cut the presence sanction substantially or eliminated it. The forgery closed that pathway.

The substance: a glucocorticoid, not a steroid

A correction is necessary here. Media reports described methylprednisolone as a "prohibited steroid" and said WADA classifies it as performance-enhancing. That is imprecise. Methylprednisolone is a glucocorticoid, listed under WADA Prohibited List class S9 — not an anabolic steroid (class S1).

The legal consequence is direct. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes. A therapeutic knee injection administered out-of-competition is entirely lawful; it becomes a violation only if residues are present in an in-competition sample.

The whole case therefore turned on route and timing relative to the competition, not on "steroid use." A road race's testing window opens at 23:59 the day before the race, so an injection given days earlier can still be caught. Aga had a genuinely strong technical defence. She destroyed it herself.

Three independent verification failures

According to the AIU statement, Aga said she took methylprednisolone to treat a knee injury and submitted a prescription in support. Investigation showed the document failed at three separate levels.

First, the clinic named on the prescription did not exist. Second, the "doctor" who allegedly issued it was a family member with no medical registration. Third, that person claimed to have used "an old prescription pad from a former workplace" — a claim the clinic explicitly disowned.

Three independent verifications, three failures. This is not an administrative slip. It is the signature of an athlete operating without a credentialed team physician.

The knee injury: plausible cause, fatal defence

Intra-articular or peri-articular methylprednisolone for knee synovitis is standard sports-medicine practice in distance runners. Aga's explanation is therefore mechanistically credible. And that credibility is precisely what makes the forgery decisive.

Had the treatment been real, the records would have existed: hospital registration, the physician's licence, the date, dose and route of injection. Producing them would not have been difficult. Instead a document was manufactured that collapsed under three checks — suggesting an established pattern of informal treatment rather than a single lapse.

The four-year tampering sanction also stems from statements made during an investigative interview, not from the document alone. Language and translation conditions in such interviews are a recurring point of contention.

Career legacy: Tokyo 2026 and three Major podium finishes

The violation is anchored to a half marathon in China in a later year, not to her whole career. Absent a finding of earlier use, results before that date — including the 2026 Tokyo Marathon title — are not automatically annulled. The report does not state the disqualification scope.

What should be stated clearly is that Aga's record was real. She finished second at three World Marathon Majors and won Tokyo in 2026. Her personal bests are reported as approximately 2:18:34 (Berlin 2026, second) and 2:20:40 (Tokyo 2026, first), though these figures are not given in the source and remain subject to independent verification.

The time and field strength of the race where the sample was collected are not disclosed. Any performance analysis would therefore be fabrication. All that is known is that she won it — implying a World Athletics Label-tier elite field with in-competition testing.

Age and return: effectively a lifetime ban

The ban runs six years from 10 September. Aga would next be eligible at roughly 38. The 2028 Olympic cycle is closed to her entirely.

Ethiopia's women's marathon depth is such that a 2:18 performer is not automatically selectable. A 38-year-old with a doping record is, in practical terms, unselectable. The six-year sanction is functionally a lifetime ban for elite purposes.

Backdating is also not a concession. Provisional suspension time counts against the ban; the athlete gains nothing in real terms.

Effect on the event landscape: zero; on governance, substantial

Competitively, this changes nothing measurable in Ethiopia's medal capacity. Aga held no global championship medal; her Major second places were commercial-tier results, not championship conversions.

The real subject is governance. The clustering of AIU road-running cases involving tampering suggests the enforcement frontier has shifted from detection to document verification. Aga's case is not an outlier; it belongs to a recognisable family in which an initial substance violation is compounded by a fabricated explanation.

China's label circuit: where income and scrutiny collide

The Chinese half marathon at which the sample was collected is not named. But races at that tier function as a lucrative, low-risk income stream for East African marathoners between Majors — large appearance fees, limited exposure.

That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races. It is reasonable to expect that the race result and prize money will be annulled, although the report does not say so — standard AIU practice is automatic disqualification of the competition where the sample was collected.

Appeal: a route exists, success is unlikely

The CAS appeal window typically runs about 21 days from the reasoned decision. But the forgery finding is document-based and hard to overturn. The prescription, the clinic's non-existence and the absent medical registration are all documentary facts, not testimonial ones.

Conclusion: the career was lost to paper, not to a substance

The bitterest fact is that a six-year ban was imposed for a glucocorticoid — a substance with no proven endurance benefit. The decision will be cited both as evidence of AIU rigour and as evidence of disproportionate enforcement against African road runners.

Aga had a legitimate defence. S9 substances are prohibited only in-competition, and an argument grounded in medical necessity, route and timing was legally strong. She replaced it with forged paper. A likely two-year absence became a six-year career end.

The case also exposes a structural failure in athlete medical support. Injured marathoners face strong pressure to mask pain, because appearance fees and sponsorship depend on availability. Glucocorticoids are the cheapest and most accessible tool for that. Where there is no credentialed team physician, there is no TUE infrastructure. And where there is no TUE infrastructure, documents get forged.

Aga's forgery is a larger signal than one individual's ethical lapse. It is the product of a system in which a lawful pathway existed but no professional was there to guide her onto it. The six-year ban is the price of that failure.